These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19532101)

  • 1. Albuminuria in heart failure: what do we really know?
    Dobre D; Nimade S; de Zeeuw D
    Curr Opin Cardiol; 2009 Mar; 24(2):148-54. PubMed ID: 19532101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart and kidney: fatal twins?
    Ritz E
    Am J Med; 2006 May; 119(5 Suppl 1):S31-9. PubMed ID: 16563946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
    Basi S; Lewis JB
    Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal disease: a common and a silent killer.
    de Zeeuw D
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S27-35. PubMed ID: 18580863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
    De Silva L; Weir MR
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):437-43. PubMed ID: 20644476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review.
    Petrie CJ; Mark PB; Weir RA
    Int J Cardiol; 2008 Aug; 128(2):154-65. PubMed ID: 18191240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression.
    Cerezo C; Ruilope LM; Segura J; Garcia-Donaire JA; de la Cruz JJ; Banegas JR; Waeber B; Rabelink TJ; Messerli FH
    J Hypertens; 2012 Jan; 30(1):204-9. PubMed ID: 22080225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment].
    Koziolek MJ; Bramlage CP; Vasko R; Grupp C; Müller GA
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1681-5. PubMed ID: 19707964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria and cardiovascular risk.
    Karalliedde J; Viberti G
    Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
    de Jong PE; Gansevoort RT; Bakker SJ
    J Nephrol; 2007; 20(4):375-80. PubMed ID: 17879201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.
    Brugts JJ; den Uil CA; Danser AH; Boersma E
    Cardiology; 2009; 112(4):303-12. PubMed ID: 18832826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.